ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/07/01 | 1,820 | 1,872 | 1,797 | 1,857 | +28 | +1.5% | 733,300 |
| 2021/06/30 | 1,782 | 1,831 | 1,782 | 1,829 | +49 | +2.8% | 758,200 |
| 2021/06/29 | 1,726 | 1,796 | 1,726 | 1,780 | +25 | +1.4% | 506,400 |
| 2021/06/28 | 1,779 | 1,780 | 1,738 | 1,755 | -8 | -0.5% | 417,500 |
| 2021/06/25 | 1,750 | 1,767 | 1,743 | 1,763 | +10 | +0.6% | 376,800 |
| 2021/06/24 | 1,792 | 1,814 | 1,749 | 1,753 | +18 | +1% | 836,900 |
| 2021/06/23 | 1,735 | 1,757 | 1,731 | 1,735 | +4 | +0.2% | 370,800 |
| 2021/06/22 | 1,686 | 1,739 | 1,670 | 1,731 | +79 | +4.8% | 543,000 |
| 2021/06/21 | 1,670 | 1,684 | 1,639 | 1,652 | -52 | -3.1% | 502,600 |
| 2021/06/18 | 1,720 | 1,748 | 1,696 | 1,704 | -3 | -0.2% | 592,500 |
| 2021/06/17 | 1,695 | 1,714 | 1,677 | 1,707 | -3 | -0.2% | 412,800 |
| 2021/06/16 | 1,696 | 1,720 | 1,696 | 1,710 | -7 | -0.4% | 282,800 |
| 2021/06/15 | 1,648 | 1,724 | 1,647 | 1,717 | +84 | +5.1% | 602,100 |
| 2021/06/14 | 1,602 | 1,657 | 1,593 | 1,633 | -20 | -1.2% | 520,400 |
| 2021/06/11 | 1,643 | 1,655 | 1,628 | 1,653 | +19 | +1.2% | 417,700 |
| 2021/06/10 | 1,648 | 1,654 | 1,621 | 1,634 | -24 | -1.4% | 461,600 |
| 2021/06/09 | 1,607 | 1,674 | 1,606 | 1,658 | +56 | +3.5% | 568,100 |
| 2021/06/08 | 1,618 | 1,655 | 1,595 | 1,602 | +22 | +1.4% | 734,000 |
| 2021/06/07 | 1,571 | 1,587 | 1,554 | 1,580 | +18 | +1.2% | 246,500 |
| 2021/06/04 | 1,547 | 1,569 | 1,542 | 1,562 | +19 | +1.2% | 249,800 |
| 2021/06/03 | 1,549 | 1,554 | 1,529 | 1,543 | -5 | -0.3% | 362,200 |
| 2021/06/02 | 1,563 | 1,570 | 1,541 | 1,548 | -15 | -1% | 254,700 |
| 2021/06/01 | 1,575 | 1,575 | 1,550 | 1,563 | ±0 | ±0% | 205,900 |
| 2021/05/31 | 1,594 | 1,595 | 1,551 | 1,563 | -5 | -0.3% | 294,900 |
| 2021/05/28 | 1,554 | 1,577 | 1,554 | 1,568 | +31 | +2% | 275,200 |
| 2021/05/27 | 1,548 | 1,552 | 1,532 | 1,537 | -21 | -1.3% | 414,300 |
| 2021/05/26 | 1,560 | 1,564 | 1,549 | 1,558 | +9 | +0.6% | 233,400 |
| 2021/05/25 | 1,566 | 1,575 | 1,543 | 1,549 | +6 | +0.4% | 340,900 |
| 2021/05/24 | 1,559 | 1,599 | 1,539 | 1,543 | -56 | -3.5% | 563,900 |
| 2021/05/21 | 1,605 | 1,610 | 1,585 | 1,599 | +14 | +0.9% | 435,300 |
| 2021/05/20 | 1,625 | 1,630 | 1,570 | 1,585 | -7 | -0.4% | 722,400 |
| 2021/05/19 | 1,544 | 1,606 | 1,533 | 1,592 | +47 | +3% | 586,900 |
| 2021/05/18 | 1,516 | 1,545 | 1,510 | 1,545 | +46 | +3.1% | 469,500 |
| 2021/05/17 | 1,500 | 1,540 | 1,495 | 1,499 | -6 | -0.4% | 771,200 |
| 2021/05/14 | 1,515 | 1,540 | 1,496 | 1,505 | -2 | -0.1% | 844,300 |
| 2021/05/13 | 1,568 | 1,589 | 1,491 | 1,507 | -141 | -8.6% | 1,667,900 |
| 2021/05/12 | 1,680 | 1,690 | 1,612 | 1,648 | -31 | -1.8% | 560,100 |
| 2021/05/11 | 1,693 | 1,708 | 1,670 | 1,679 | -26 | -1.5% | 372,000 |
| 2021/05/10 | 1,729 | 1,729 | 1,700 | 1,705 | -3 | -0.2% | 330,200 |
| 2021/05/07 | 1,728 | 1,743 | 1,703 | 1,708 | -17 | -1% | 287,700 |
| 2021/05/06 | 1,730 | 1,753 | 1,719 | 1,725 | +11 | +0.6% | 342,300 |
| 2021/04/30 | 1,745 | 1,745 | 1,708 | 1,714 | -23 | -1.3% | 391,200 |
| 2021/04/28 | 1,770 | 1,776 | 1,733 | 1,737 | -37 | -2.1% | 539,300 |
| 2021/04/27 | 1,822 | 1,825 | 1,774 | 1,774 | -51 | -2.8% | 380,000 |
| 2021/04/26 | 1,810 | 1,828 | 1,788 | 1,825 | +19 | +1.1% | 298,800 |
| 2021/04/23 | 1,842 | 1,846 | 1,806 | 1,806 | -41 | -2.2% | 271,500 |
| 2021/04/22 | 1,849 | 1,862 | 1,832 | 1,847 | +21 | +1.2% | 294,500 |
| 2021/04/21 | 1,843 | 1,858 | 1,825 | 1,826 | -48 | -2.6% | 414,800 |
| 2021/04/20 | 1,892 | 1,893 | 1,866 | 1,874 | -22 | -1.2% | 260,100 |
| 2021/04/19 | 1,915 | 1,933 | 1,894 | 1,896 | -17 | -0.9% | 264,400 |
801～
850
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
